Abstract: The present invention concerns a conjugate of a domain I ?2GP1 polypeptide with a water-soluble polymer, wherein the polymer is bound via two cysteine residues derived from a disulfide bridge in the domain I ?2GP1 polypeptide.

Abstract: A mobile telephone (10), an advertiser, broadcasts an advertisement over a wireless short range piconet link to another mobile telephone (12), a consumer. The advertisement is broadcast with a predetermined set of classification tags and the consumer phone (12) has a filter set to accept only certain adverts. When an advertisement of interest is received by the consumer phone (12) it requests further details automatically via the piconet link and the advertiser phone (10) provides then automatically via the piconet link. When the consumer wishes to reply to the advertisement they contact the advertiser phone (10), or an advertiser device, via a long range cellular link (16).

Abstract: The invention pertains, at least in part, to a method for treating metabolic syndrome in a subject. The method includes administering to a subject an effective amount of a compound of formula (I). The compound of formula (I) is: wherein R1 and R2 are independently H or methyl, and enantiomers and pharmaceutically acceptable salts thereof.

Abstract: A data item 11 is cyclically broadcast from a wireless transceiver 1 as a number of individual data segments 13. Receipt of all of the individual data segments 13 by a mobile device 9 is required to successfully receive the entirety of the data item 11. The time required to transmit all of the data segments 13 is increased by transmitting each data segment 13 at a minimum time interval from one another, or alternatively or additionally varying the rate of data transmission. A mobile device user is therefore required to remain within the locality of the wireless transceiver 1 for a minimum period of time.

Abstract: The invention pertains, at least in part, to a method for treating metabolic syndrome in a subject. The method includes administering to a subject an effective amount of a compound of formula (I). The compound of formula (I) is: wherein R1 and R2 are independently H or methyl, and enantiomers and pharmaceutically acceptable salts thereof.